+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Contact Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Febrile Neutropenia - Pipeline Insight, 2025 - Product Thumbnail Image

Febrile Neutropenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Ankylosing Spondylitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ankylosing Spondylitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Allergic Conjunctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Allergic Conjunctivitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Allergic Rhino-Conjunctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Allergic Rhino-Conjunctivitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hereditary Angioedema - Pipeline Insight, 2025 - Product Thumbnail Image

Hereditary Angioedema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Insight, 2025 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Toll-like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
CXCR4 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CXCR4 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Kallikrein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Kallikrein Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Psoriatic Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Uveitis - Pipeline Insight, 2025 - Product Thumbnail Image

Uveitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alopecia - Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nasal Polyps - Pipeline Insight, 2025 - Product Thumbnail Image

Nasal Polyps - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cutaneous Lupus Erythematosus- Pipeline Insight, 2025 - Product Thumbnail Image

Cutaneous Lupus Erythematosus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more